Tyra Biosciences to Present at Upcoming Investor Conferences
Provided By PR Newswire
Last update: Nov 13, 2024
CARLSBAD, Calif., Nov. 13, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced that company management will participate in the following investor conferences:
Read more at prnewswire.com
